Susana Rives

9.6k total citations
70 papers, 1.4k citations indexed

About

Susana Rives is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Susana Rives has authored 70 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 25 papers in Public Health, Environmental and Occupational Health and 20 papers in Hematology. Recurrent topics in Susana Rives's work include Acute Lymphoblastic Leukemia research (20 papers), CAR-T cell therapy research (14 papers) and Childhood Cancer Survivors' Quality of Life (11 papers). Susana Rives is often cited by papers focused on Acute Lymphoblastic Leukemia research (20 papers), CAR-T cell therapy research (14 papers) and Childhood Cancer Survivors' Quality of Life (11 papers). Susana Rives collaborates with scholars based in Spain, France and United States. Susana Rives's co-authors include Elı́as Campo, Antonio Martı́nez, Emili Montserrat, Luís Colomo, Armando López‐Guillermo, Francesc Bosch, Jesús Estella, Lluı́s Colomo, Marı́a Perales and Armando López‐Guillermo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Susana Rives

67 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susana Rives Spain 20 712 604 329 274 231 70 1.4k
Diane Coso France 25 582 0.8× 376 0.6× 318 1.0× 929 3.4× 212 0.9× 78 1.7k
Beenu Thakral United States 18 348 0.5× 411 0.7× 406 1.2× 499 1.8× 132 0.6× 114 1.2k
Atsushi Kikuta Japan 21 596 0.8× 256 0.4× 145 0.4× 654 2.4× 212 0.9× 118 1.5k
Daniele Laszlò Italy 20 709 1.0× 649 1.1× 350 1.1× 597 2.2× 94 0.4× 67 1.6k
M. J. Barnett Canada 20 388 0.5× 220 0.4× 243 0.7× 676 2.5× 173 0.7× 43 1.3k
Nabih Azar France 19 245 0.3× 344 0.6× 357 1.1× 295 1.1× 230 1.0× 41 1.3k
P. Meusers Germany 18 689 1.0× 648 1.1× 386 1.2× 519 1.9× 201 0.9× 43 1.5k
Gunnar Grimfors Sweden 19 405 0.6× 350 0.6× 407 1.2× 751 2.7× 252 1.1× 41 1.4k
K Kawa Japan 21 715 1.0× 506 0.8× 139 0.4× 677 2.5× 131 0.6× 51 1.6k
Görgün Akpek United States 25 465 0.7× 296 0.5× 399 1.2× 1.1k 4.0× 403 1.7× 65 2.0k

Countries citing papers authored by Susana Rives

Since Specialization
Citations

This map shows the geographic impact of Susana Rives's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susana Rives with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susana Rives more than expected).

Fields of papers citing papers by Susana Rives

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susana Rives. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susana Rives. The network helps show where Susana Rives may publish in the future.

Co-authorship network of co-authors of Susana Rives

This figure shows the co-authorship network connecting the top 25 collaborators of Susana Rives. A scholar is included among the top collaborators of Susana Rives based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susana Rives. Susana Rives is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bobillo‐Pérez, Sara, et al.. (2025). Role of procalcitonin, C-reactive protein and ferritin in cytokine release syndrome after CAR T-cell therapy in children and young adults. Biomarkers. 30(2). 115–122. 2 indexed citations
2.
Fernández, Guerau, et al.. (2025). RNA‐sequencing: A reliable tool to unveil transcriptional landscape of paediatric B‐other acute lymphoblastic leukaemia. British Journal of Haematology. 206(5). 1355–1365.
3.
Gómez‐González, Soledad, Sara Pérez‐Jaume, Susana Rives, et al.. (2023). A miRNA signature related to stemness identifies high‐risk patients in paediatric acute myeloid leukaemia. British Journal of Haematology. 202(1). 96–110. 5 indexed citations
4.
Rössig, Claudia, Andrew D.J. Pearson, Gilles Vassal, et al.. (2023). Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed. Journal of Clinical Oncology. 42(3). 253–257. 7 indexed citations
5.
Bobillo‐Pérez, Sara, Anna Faura, Albert Català, et al.. (2023). Risk factors and outcome of Chimeric Antigen Receptor T-Cell patients admitted to Pediatric Intensive Care Unit: CART-PICU study. Frontiers in Immunology. 14. 1219289–1219289. 7 indexed citations
6.
Buechner, Jochen, Ignazio Caruana, Annette Künkele, et al.. (2022). Chimeric Antigen Receptor T-Cell Therapy in Paediatric B-Cell Precursor Acute Lymphoblastic Leukaemia: Curative Treatment Option or Bridge to Transplant?. Frontiers in Pediatrics. 9. 784024–784024. 16 indexed citations
7.
Laetsch, Theodore W., Shannon L. Maude, Adriana Balduzzi, et al.. (2022). Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemia. Leukemia. 36(6). 1508–1515. 26 indexed citations
8.
Buechner, Jochen, Stephan A. Grupp, Hidefumi Hiramatsu, et al.. (2021). Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy. Blood Advances. 5(2). 593–601. 39 indexed citations
9.
Rives, Susana. (2021). CAR T cells in CNS-relapsed leukaemia: one step forward. The Lancet Haematology. 8(10). e675–e676. 1 indexed citations
10.
Faura, Anna, Sara Bobillo‐Pérez, Albert Català, et al.. (2021). Outcomes for paediatric acute leukaemia patients admitted to the paediatric intensive care unit. European Journal of Pediatrics. 181(3). 1037–1045. 5 indexed citations
11.
12.
Barba, Pere, José Luís Dapena, Pau Montesinos, & Susana Rives. (2017). Asparaginasas en el tratamiento de la leucemia linfoblástica aguda. Medicina Clínica. 148(5). 225–231. 3 indexed citations
13.
Rives, Susana, et al.. (2016). Assessment of anaerobic blood cultures in pediatric oncology patients. Enfermedades Infecciosas y Microbiología Clínica. 35(1). 33–36. 5 indexed citations
14.
Rives, Susana, et al.. (2013). Successful port-a-cath salvage using linezolid in children with acute leukemia. Pediatric Blood & Cancer. 60(9). E103–E105. 2 indexed citations
15.
Berrueco, Rubén, Andrés Antón, Susana Rives, et al.. (2013). Multiplex real-time PCR for prompt diagnosis of an outbreak of human parainfluenza 3 virus in children with acute leukemia. Infection. 41(6). 1171–1175. 8 indexed citations
16.
Rives, Susana, Heike L. Pahl, Lourdes Florensa, et al.. (2007). Molecular genetic analyses in familial and sporadic congenital primary erythrocytosis. Haematologica. 92(5). 674–677. 22 indexed citations
17.
Rives, Susana, et al.. (2005). Idiopathic Hypereosinophilic Syndrome in Children. Journal of Pediatric Hematology/Oncology. 27(12). 663–665. 29 indexed citations
18.
Urrea, Mireya, Susana Rives, Ofelia Cruz, et al.. (2004). Nosocomial infections among pediatric hematology/oncology patients: Results of a prospective incidence study. American Journal of Infection Control. 32(4). 205–208. 36 indexed citations
19.
Colomo, Luís, Florence Loong, Susana Rives, et al.. (2004). Diffuse Large B-cell Lymphomas With Plasmablastic Differentiation Represent a Heterogeneous Group of Disease Entities. The American Journal of Surgical Pathology. 28(6). 736–747. 293 indexed citations
20.
Álvarez, Ana García, Susana Rives, Benet Nomdedeu, & M. A. Pereira. (1999). Massive hemolysis in Clostridium perfringens infection.. PubMed. 84(6). 571–3. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diane Coso Breakdown of academic impact, for papers by Beenu Thakral Breakdown of academic impact, for papers by Atsushi Kikuta Breakdown of academic impact, for papers by Daniele Laszlò Breakdown of academic impact, for papers by M. J. Barnett Breakdown of academic impact, for papers by Nabih Azar Breakdown of academic impact, for papers by P. Meusers Breakdown of academic impact, for papers by Gunnar Grimfors Breakdown of academic impact, for papers by K Kawa Breakdown of academic impact, for papers by Görgün Akpek
Rankless by CCL
2026